Tag: UBS
WACKER CHEMIE AG: UBS maintains its buy recommendation
In a research note, UBS analyst Andrew Stott maintained his recommendation on the stock and advises it to buy. The target price is modified upwards to EUR 190 against EUR…
SYMRISE AG: Positive opinion of UBS
UBS is positive and recommends the stock for purchase. The target price is set at 141 against 140 EUR. Zonebourse with dpa-AFX Analyzer 2022 All the news about SYMRISE AG…
EVONIK: UBS reiterates its positive opinion on the stock
In a research note published by Andrew Stott, the broker UBS advises to be interested in the title with a buying opinion. The target price remains fixed at 34 EUR.…
COVESTRO: UBS still neutral on the issue
In a research note published by Andrew Stott, UBS reiterated its neutral view on the stock. Previously at EUR 53, the price target has been slightly modified and is now…
GIVAUDAN AG: UBS maintains its neutral opinion
Analyst Andrew Stott does not change his recommendation. UBS remains neutral on the matter. The price target has been modified downwards and…
IBM: UBS downgrades its advice on the title
(CercleFinance.com) – UBS is lowering its advice on IBM stock from ‘neutral’ to ‘sell’, with a price target reduced from $ 136 to $ 124. The analyst is indeed revising…
Novartis: UBS raises its target, but remains ‘neutral’
(CercleFinance.com) – UBS on Friday raised its price target on Novartis, which rose from 80 to 82 Swiss francs, while declaring to expect “weak growth” from the pharmaceutical group this…
UBS: the title goes up, an analyst raises his target
(CercleFinance.com) – The title is well oriented at the end of the session as Jefferies reaffirms its ‘buy’ recommendation on UBS Group with a potential increase of around 35% compared…
Sanofi: in the green after the positive analysis of UBS
(CercleFinance.com) – The title ends in the green after the raising of the objective of UBS. The analysis office on Thursday raised its price target on the Sanofi title, explaining…
LUFTHANSA AG: UBS neutral on the dossier
New neutral recommendation for UBS on the title. Analyst Jarrod Castle doesn’t change his opinion. The price target is slightly modified and…
IAG: UBS still positive
UBS is positive and recommends the stock buy. The price objective is fixed at 220 against 225 GBX. Zonebourse with dpa-AFX Analyzer 2022 All the news on INTERNATIONAL CONSOLIDATED AIRLINES…
AIR FRANCE-KLM: UBS maintains its neutral opinion
UBS via its analyst Jarrod Castle confirms its neutral recommendation on the file. The price target has been modified downward and now set at 4.10 EUR against 4.50 EUR previously.…